Radial access versus femoral access in myocardial infarction – a single-center experience

  • Vojko Kanič Department of Cardiology and Angiology, Division of Internal Medicine, University Medical Centre Maribor, Maribor, Slovenia
  • Igor Balevski University Medical Center Maribor, Division of Internal Medicine, Department of Cardiology and Angiology, Ljubljanska ulica 5, 2000 Maribor
  • Samo Granda University Medical Center Maribor, Division of Internal Medicine, Department of Cardiology and Angiology, Ljubljanska ulica 5, 2000 Maribor
  • Franjo Husam Naji University Medical Center Maribor, Division of Internal Medicine, Department of Cardiology and Angiology, Ljubljanska ulica 5, 2000 Maribor
  • Igor Krajnc University Medical Center Maribor, Division of Internal Medicine, Department of Cardiology and Angiology, Ljubljanska ulica 5, 2000 Maribor, Slovenia
  • Gregor Kompara University Medical Center Maribor, Division of Internal Medicine, Department of Cardiology and Angiology, Ljubljanska ulica 5, 2000 Maribor
Keywords: myocardial infarction, percutaneous coronary intervention, radial access

Abstract

Background

Data on the relationship between radial access (RA) and outcome in patients with myocardial infarction (MI) undergoing percutaneous coronary intervention (PCI) are inconclusive. The aim of our study was to assess whether RA is associated with 30-day mortality in patients with MI undergoing percutaneous coronary intervention in our center or whether the possible benefit of RA is the result of less bleeding and other confounding factors.

Methods

We retrospectively studied 3501 consecutive patients with MI who underwent PCI between January 2012 and December 2016. The 30-day mortality in the RA and femoral access (FA) groups was observed. Data were analyzed using descriptive statistics.

Results

RA patients had a significantly lower 30-day unadjusted mortality [53(3.8%) patients died in the RA group compared to 207(9.8%) patients in the FA group; p<0.0001]. After adjustments for confounders, the difference was no longer significant (adjusted OR: 0.84; 95% CI: 0.58 to 1.22). Cardiogenic shock, age over 70 years, hypertension, hyperlipidemia, anemia on admission, renal dysfunction on admission, ST-elevation MI, bleeding, the contrast volume/GFR ratio, but not RA, predicted 30-day mortality.

 

Conclusion

RA was not associated with 30-day mortality in patients with MI undergoing PCI. Our study result suggests that the better outcome in the RA group was influenced by confounding factors, especially bleeding and hemodynamic impairment.

 

 

 

 

 

Downloads

Download data is not yet available.

References

Bauer T, Hochadel M, Brachmann J, Schächinger V, Boekstegers P, Zrenner B, et al.; Arbeitsgemeinschaft leitende kardiologische Krankenhausärzte (ALKK). Use and outcome of radial versus femoral approach for primary PCI in patients with acute ST elevation myocardial infarction without cardiogenic shock: results from the ALKK PCI registry. Catheter Cardiovasc Interv. 2015 Oct;86 Suppl 1:S8–14. https://doi.org/10.1002/ccd.25987 PMID:25945803

Hinohara TT, Rao SV. Current State of Radial Artery Catheterization in ST-Elevation Myocardial Infarction. Prog Cardiovasc Dis. 2015 Nov-Dec;58(3):241–6. https://doi.org/10.1016/j.pcad.2015.07.007 PMID:26206109

Ferrante G, Rao SV, Jüni P, Da Costa BR, Reimers B, Condorelli G, et al. Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials. JACC Cardiovasc Interv. 2016 Jul;9(14):1419–34. https://doi.org/10.1016/j.jcin.2016.04.014 PMID:27372195

Valgimigli M, Gagnor A, Calabró P, Frigoli E, Leonardi S, Zaro T, et al.; MATRIX Investigators. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. Lancet. 2015 Jun;385(9986):2465–76. https://doi.org/10.1016/S0140-6736(15)60292-6 PMID:25791214

Andò G, Capodanno D. Radial Access Reduces Mortality in Patients With Acute Coronary Syndromes: Results From an Updated Trial Sequential Analysis of Randomized Trials. JACC Cardiovasc Interv. 2016 Apr;9(7):660–70. https://doi.org/10.1016/j.jcin.2015.12.008 PMID:27056303

Andò G, Capodanno D. Radial Versus Femoral Access in Invasively Managed Patients With Acute Coronary Syndrome: A Systematic Review and Meta-analysis. Ann Intern Med. 2015 Dec;163(12):932–40. https://doi.org/10.7326/M15-1277 PMID:26551857

Jolly SS, Yusuf S, Cairns J, Niemelä K, Xavier D, Widimsky P, et al.; RIVAL trial group. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011 Apr;377(9775):1409–20. https://doi.org/10.1016/S0140-6736(11)60404-2 PMID:21470671

Kołtowski L, Filipiak KJ, Kochman J, Pietrasik A, Rdzanek A, Huczek Z, et al. Access for percutaneous coronary intervention in ST segment elevation myocardial infarction: radial vs. femoral—a prospective, randomised clinical trial (OCEAN RACE). Kardiol Pol. 2014;72(7):604–11. PMID:24671918

Romagnoli E, Biondi-Zoccai G, Sciahbasi A, Politi L, Rigattieri S, Pendenza G, et al. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol. 2012 Dec;60(24):2481–9. https://doi.org/10.1016/j.jacc.2012.06.017 PMID:22858390

Dobies DR, Barber KR, Cohoon AL. Analysis of safety outcomes for radial versus femoral access for percutaneous coronary intervention from a large clinical registry. Open Heart. 2016 Aug;3(2):e000397. https://doi.org/10.1136/openhrt-2015-000397 PMID:27547427

Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal 2016;37:1257-315.

is Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al.; ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018 Jan;39(2):119–77. PMID:28886621

Nutritional anaemias. Report of a WHO scientific group. Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity VMNIS. Geneva, Switzerland: World Health Organization; 1968.

Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011 Jun;123(23):2736–47. https://doi.org/10.1161/CIRCULATIONAHA.110.009449 PMID:21670242

Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, et al.; Chronic Kidney Disease Epidemiology Collaboration. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007 Apr;53(4):766–72. https://doi.org/10.1373/clinchem.2006.077180 PMID:17332152

White CW. Simplicity’s virtue scorned. Precision comes to TIMI flow grading and the results are ...surprising. Circulation. 1996 Mar;93(5):853–6. https://doi.org/10.1161/01.CIR.93.5.853 PMID:8598074

Hsieh FY. Sample size tables for logistic regression. Stat Med. 1989 Jul;8(7):795–802. https://doi.org/10.1002/sim.4780080704 PMID:2772439

Chen H, Cohen P, Chen S. How Big is a Big Odds Ratio? Interpreting the Magnitudes of Odds Ratios in Epidemiological Studies. Commun Stat Simul Comput. 2010;39(4):860–4. https://doi.org/10.1080/03610911003650383.

Hsieh FY, Lavori PW, Cohen HJ, Feussner JR. An overview of variance inflation factors for sample-size calculation. Eval Health Prof. 2003 Sep;26(3):239–57. https://doi.org/10.1177/0163278703255230 PMID:12971199

Hamon M, Filippi-Codaccioni E, Riddell JW, Lepage O. Prognostic impact of major bleeding in patients with acute coronary syndromes.A systematic review and meta-analysis. EuroIntervention. 2007 Nov;3(3):400–8. https://doi.org/10.4244/EIJV3I3A71 PMID:19737724

Maréchaux S, Barrailler S, Pinçon C, Decourcelle V, Guidez T, Braun S, et al. Prognostic value of hemoglobin decline over the GRACE score in patients hospitalized for an acute coronary syndrome. Heart Vessels. 2012 Mar;27(2):119–27. https://doi.org/10.1007/s00380-011-0127-3 PMID:21562778

Meneveau N, Schiele F, Seronde MF, Descotes-Genon V, Oettinger J, Chopard R, et al.; Reseau de Cardiologie de Franche Comte. Anemia for risk assessment of patients with acute coronary syndromes. Am J Cardiol. 2009 Feb;103(4):442–7. https://doi.org/10.1016/j.amjcard.2008.10.023 PMID:19195499

Lawler PR, Filion KB, Dourian T, Atallah R, Garfinkle M, Eisenberg MJ. Anemia and mortality in acute coronary syndromes: a systematic review and meta-analysis. Am Heart J. 2013 Feb;165(2):143–53.e5. https://doi.org/10.1016/j.ahj.2012.10.024 PMID:23351816

Younge JO, Nauta ST, Akkerhuis KM, Deckers JW, van Domburg RT. Effect of anemia on short- and long-term outcome in patients hospitalized for acute coronary syndromes. Am J Cardiol. 2012 Feb;109(4):506–10. https://doi.org/10.1016/j.amjcard.2011.09.046 PMID:22152975

Kanic V, Kompara G, Vollrath M, Suran D, Kanic Z. Sex-Related Anemia Contributes to Disparities in Outcome of Patients Younger Than 60 Years with ST-Elevation Myocardial Infarction. J Womens Health (Larchmt). 2018 Jun;27(6):755–60. https://doi.org/10.1089/jwh.2017.6644 PMID:29377747

Aronson D, Suleiman M, Agmon Y, Suleiman A, Blich M, Kapeliovich M, et al. Changes in haemoglobin levels during hospital course and long-term outcome after acute myocardial infarction. Eur Heart J. 2007 Jun;28(11):1289–96. https://doi.org/10.1093/eurheartj/ehm013 PMID:17363447

Bassand JP, Afzal R, Eikelboom J, Wallentin L, Peters R, Budaj A, et al.; OASIS 5 and OASIS 6 Investigators. Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. Eur Heart J. 2010 Jan;31(1):50–8. https://doi.org/10.1093/eurheartj/ehp401 PMID:19825809

Andò G, Cortese B, Russo F, Rothenbühler M, Frigoli E, Gargiulo G, et al.; MATRIX Investigators. Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX. J Am Coll Cardiol. 2017 May;69(21):2592–603. https://doi.org/10.1016/j.jacc.2017.02.070 PMID:28528767

Narula A, Mehran R, Weisz G, Dangas GD, Yu J, Généreux P, et al. Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy. Eur Heart J. 2014 Jun;35(23):1533–40. https://doi.org/10.1093/eurheartj/ehu063 PMID:24603308

Andò G, Costa F, Trio O, Oreto G, Valgimigli M. Impact of vascular access on acute kidney injury after percutaneous coronary intervention. Cardiovasc Revasc Med. 2016 Jul-Aug;17(5):333–8. https://doi.org/10.1016/j.carrev.2016.03.004 PMID:27050627

Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. Am Heart J. 2009 Jan;157(1):132–40. https://doi.org/10.1016/j.ahj.2008.08.023 PMID:19081409

Published
2019-10-06
How to Cite
1.
Kanič V, Balevski I, Granda S, Naji F, Krajnc I, Kompara G. Radial access versus femoral access in myocardial infarction – a single-center experience. TEST ZdravVestn [Internet]. 6Oct.2019 [cited 26Apr.2024];88(7-8):327-3. Available from: http://vestnik-dev.szd.si/index.php/ZdravVest/article/view/2849
Section
Original article